Pine Pharmaceuticals, LLC
Address
355 Riverwalk Parkway
Tonawanda
New York
14150
Additional
Project AKA : Chestnut Point
Approval Date : 01-27-2021
Total Cost : $8,615,000.00
Approval Date : 01-27-2021
Total Cost : $8,615,000.00
Project Details
In 2017, with IDA assistance, Pine Pharmaceutical constructed a 25,000 sq. ft. facility in the Riverview Solar Technology Park. Since that time the company’s operations have grown and is now in need of additional space. They will be constructing a 50,000 aq. ft. expansion to the existing facility. Since Pine is a sterile compounder, significant purchases will be made to equip new cleanrooms.
Project Files
Project Log:
Public Hearing Transcript:
Agent Agreement:
Inducement Resolution:
PILOT Agreement:
Economic Impact Analysis:
Status Details
12/30/2020 - Public hearing held.
· 01/27/2021 - The project is in compliance with the Town of Tonawanda Generic Environmental Impact Statement and no further SEQRA compliance is required by ECIDA Board.
· 01/27/2021 - Lease/Leaseback Inducement Resolution presented to the Board of Directors